Therapeutic Response Evaluation by CTC Expansion System

Status Enrolling by invitation

Clinical Trial Summary

Among biomarkers, CTCs are a convenient, sensitive and biologically informative option. CTC detection could be considered a real-time "liquid biopsy" approach and contains several advantages such as minimally invasive, easy and safe to perform, and multiple samples can be taken over time, better prognosis to indicate an elevated risk of metastases, improved therapy monitoring, providing live disease status information., However, the number of CTCs is very low, so the establishment of cell culture from CTCs becomes the most challenging over the past year. In this study, we develop a short-term CTC expansion protocol combined with a new surface coating technique. Expanded circulating tumor cells will provide genetic information and develop oncology drug screening platform, which provides an opportunity to monitor response to therapy noninvasively.

Clinical Trial Description

CTC detection could be considered a real-time "liquid biopsy" approach and contains several advantages such as minimally invasive, easy and safe to perform, and multiple samples can be taken over time, better prognosis to indicate an elevated risk of metastases, improved therapy monitoring, providing live disease status information., However, the number of CTCs is very low so the establishment of cell culture from CTCs becomes the most challenging over the past year. In this proposal we will develop a short-term CTC expansion protocol through combine with a new type of surface coating technique. Expanded circulating tumor cells will provide genetic information and develop oncology drug screening platform which provide an opportunity to noninvasively monitor response to therapy. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04972461
Study type	Observational
Source	Taipei Medical University Hospital
Contact
Status	Enrolling by invitation
Phase
Start date	August 8, 2018
Completion date	August 7, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT02072616` - Detection of Circulating Tumor Cells for the Diagnostic of Pancreatic Adenocarcinoma.	Phase 3
Completed	`NCT02808884` - Cancer DNA Screening Pilot Study (CANDACE)	N/A
Recruiting	`NCT06068348` - Liquid Biopsy Collection Study
Completed	`NCT02335151` - CTC Pancreatic Adenocarcinoma	Phase 4
Completed	`NCT01015625` - Primary Operation in SYnchronous meTastasized InVasivE Breast Cancer	N/A
Recruiting	`NCT02602938` - Aspirin on CTCs of Advanced Breast and Colorectal Cancer	Phase 2
Completed	`NCT02499458` - Prospective Validation of Circulating Tumor Cells & Circulating Endothelial Cells as Biomarkers in Renal Cancer
Completed	`NCT03101046` - Treatment of Metastatic Castrate Resistant Prostate Cancer Patients According to Circulating Tumor Cells Kinetic	Phase 2
Completed	`NCT02449837` - Investigation of Circulating Tumor Cells From Cancer Patients Undergoing Radiation Therapy
Recruiting	`NCT02451384` - According CTC to Compare the Influences of Different Methods to Remove the PDAC	N/A
Recruiting	`NCT01052818` - Therapeutic and Prognostic Impact of Circulating Tumor Cells in Peripheral Blood in Patients With Non Small-cell Lung Cancer	N/A
Not yet recruiting	`NCT04239105` - Detection of Circulating Tumor Cells in Breast Cancer Patients Using a Novel Microfluidic and Raman Spectrum Device
Recruiting	`NCT02554448` - Detection of CTCs in Stage III Rectal Cancer Patients Undergoing Neoadjuvant Therapy	N/A
Recruiting	`NCT03156777` - Application Value of CTCs Detection for Advanced Gastric Cancer Patients	N/A
Completed	`NCT02345473` - Detection and Clinical Significance of Circulating Cancer Cells in Patient Undergoing Radical Cystectomy	N/A
Not yet recruiting	`NCT04229121` - Clinical Sensitivity Verification Study of Circulating Tumor Cells Gene Mutation Detection From Advanced NSCLC Patients
Completed	`NCT02955173` - Significance of Circulating Tumor Cells in the Treatment of Gastric and Rectal Cancer	N/A
Completed	`NCT03340844` - Role of CTC´s Spread During Pancreaticoduodenectomy in Patients With Pancreatic and Periampullary Tumors	N/A
Active, not recruiting	`NCT03381326` - CTC, Free DNA, Stem Cells and EMT-related Antigens as Biomarkers of Activity of Cabazitaxel in CRPC.
Completed	`NCT05502458` - Effect of Propofol and Desflurane on Nucleic Acid of Liver Circulating Tumor	Phase 2